Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seitz-Polski

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 2, 2013
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathyCornelia Dähnrich, Lars Komorowski, Christian Probst, et al.
Annals of Clinical and Translational Neurology|June 29, 2025
Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti-GFAP AntibodiesMichael Levraut, Romain Marignier, Mikael Cohen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2019
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous NephropathyBarbara Seitz-Polski, Karine Dahan, Hanna Debiec, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 27, 2014
Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patientsBarbara Seitz-Polski, Christine Payré, Damien Ambrosetti, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patientsAlexandre Gérard, Jerome Doyen, Marion Cremoni, et al.
Ebiomedicine|October 2, 2022
Air pollution exposure induces a decrease in type II interferon response: A paired cohort studyJonathan Allouche, Marion Cremoni, Vesna Brglez, et al.
Frontiers in Medicine|February 15, 2021
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 PatientsCaroline Ruetsch, Vesna Brglez, Marion Crémoni, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 1, 2020
Multi-Autoantibody Signature and Clinical Outcome in Membranous NephropathyGian Marco Ghiggeri, Barbara Seitz-Polski, Joana Justino, et al.
Journal of Immunology Research|February 22, 2020
Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement ActivationMaël Lateb, Hajar Ouahmi, Christine Payré, et al.
Frontiers in Immunology|October 13, 2022
Low baseline IFN-γ response could predict hospitalization in COVID-19 patientsMarion Cremoni, Jonathan Allouche, Daisy Graça, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 2, 2013
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathyCornelia Dähnrich, Lars Komorowski, Christian Probst, et al.
Annals of Clinical and Translational Neurology|June 29, 2025
Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti-GFAP AntibodiesMichael Levraut, Romain Marignier, Mikael Cohen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2019
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous NephropathyBarbara Seitz-Polski, Karine Dahan, Hanna Debiec, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 27, 2014
Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patientsBarbara Seitz-Polski, Christine Payré, Damien Ambrosetti, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patientsAlexandre Gérard, Jerome Doyen, Marion Cremoni, et al.
Ebiomedicine|October 2, 2022
Air pollution exposure induces a decrease in type II interferon response: A paired cohort studyJonathan Allouche, Marion Cremoni, Vesna Brglez, et al.
Frontiers in Medicine|February 15, 2021
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 PatientsCaroline Ruetsch, Vesna Brglez, Marion Crémoni, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 1, 2020
Multi-Autoantibody Signature and Clinical Outcome in Membranous NephropathyGian Marco Ghiggeri, Barbara Seitz-Polski, Joana Justino, et al.
Journal of Immunology Research|February 22, 2020
Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement ActivationMaël Lateb, Hajar Ouahmi, Christine Payré, et al.
Frontiers in Immunology|October 13, 2022
Low baseline IFN-γ response could predict hospitalization in COVID-19 patientsMarion Cremoni, Jonathan Allouche, Daisy Graça, et al.
Pageof 8